Bristol Myers: Quality Fundamentals Suppressed By Interest Rates

JHVEPhoto Overview Every so often, there comes a time when dividend investors can catch a once-in-a-lifetime sale on a high-quality company. I believe that Bristol Myers Squibb (NYSE:BMY) is this next opportunity, as the price has fallen nearly 40% over the last year. This price movement severely underperforms the greater health care sector (XLV) over the same time period. BMY seems to be highly vulnerable to the rise in interest rates and as rates remain at decade highs, this heavily suppresses the lev ...